Lyme Meningoradiculitis: Case Reports and Literature Review

1. Ruxandra Calin, Adriana Hristea, Radu Tanasescu (2012). Central Nervous System Involvement in Lyme Disease - Making the Diagnosis and Choosing the Correct Treatment, Miscellanea on Encephalopathies, Radu Tanasescu (Ed.), ISBN: 978-953-51-0499-5, InTech, DOI: 10.5772/37669.10.5772/37669Search in Google Scholar

2. Hildenbrand P, Craven DE, Jones R, Nemeskal P. Lyme neuroborreliosis: manifestations of a rapidly emerging zoonosis. AJNR Am J Neuroradiol. 2009;30(6):1079-87. doi: 10.3174/ajnr.A1579.10.3174/ajnr.A1579Search in Google Scholar

3. Blanc F, Gebly. Neurologic and psychiatric manifestations of Lyme disease. Medecine et Maladies Infectieuses 2007;37(7-8):435-445.10.1016/j.medmal.2006.01.025Search in Google Scholar

4. Zhang Y, Lafontant G, Bonner FJ Jr. Lyme neuroborreliosis mimics stroke: a case report. Arch Phys Med Rehabil. 2000;81(4):519-521.10.1053/mr.2000.4431Search in Google Scholar

5. Garcia-Monco JC, Benach JI. Lyme neuroborreliosis. Ann Neurol. 1995;37:691-702.10.1002/ana.410370602Search in Google Scholar

6. Reik L, Steere AC, Bartenhagen NH, Shope RE, Malawista SE. Neurologic abnormalities of Lyme disease. Medicine (Baltimore). 1979;58(4):281-294.10.1097/00005792-197907000-00001Search in Google Scholar

7. Steere AC. Lyme disease. N Engl J Med 2001;345(2):115-125.10.1056/NEJM200107123450207Search in Google Scholar

8. Subedi S, Dickeson DJ, Branley JM. First report of Lyme neuroborreliosis in a returned Australian traveller. Med J Aust. 2015;203(1):39-40.10.5694/mja14.01592Search in Google Scholar

9. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003;362(9396):1639-1647.10.1016/S0140-6736(03)14798-8Search in Google Scholar

10. Rahn DW, Felz MW. Lyme disease update. Current approach to early, disseminated, and late disease. Postgrad Med. 1998;103(5):51-4,57-9,63-4passim.10.3810/pgm.1998.05.4829590986Search in Google Scholar

11. Dessau RB, Espenhain L, Mølbak K, Krause TG, Voldstedlund M. Improving national surveillance of Lyme neuroborreliosis in Denmark through electronic reporting of specific antibody index testing from 2010 to 2012. Euro Surveill. 2015;20(28).pii:21184.10.2807/1560-7917.ES2015.20.28.21184Search in Google Scholar

12. Tobias A Rupprecht, Volker Fingerle. Neuroborreliosis: pathogenesis, symptoms, diagnosis and treatment. Future Neurology. 2011;6(2):273-289. DOI: 10.2217/fnl.10.89.10.2217/fnl.10.89Search in Google Scholar

13. Jassam YN, Thaler DE. Lyme meningo-radiculitis responsive to oral doxycycline therapy in the USA. Oxf Med Case Reports. 2014;2014(9):162-163. doi: 10.1093/omcr/omu061. eCollection 2014.10.1093/omcr/omu061Search in Google Scholar

14. Halperin JJ. Nervous system lyme disease: is there a controversy? Semin Neurol. 2011;31(3):317-324. doi: http://dx.doi.org/10.1055/s-0031-1287652.Search in Google Scholar

15. Halperin JJ. Chronic Lyme disease: misconceptions and challenges for patient management. Infect Drug Resist. 2015;8:119-28. doi: 10.2147/IDR.S66739. eCollection 2015.10.2147/IDR.S66739Search in Google Scholar

16. Garin C, Bujadoux A. Paralysie par les tiques. (tick paralysis). J Med Lyon. 1922;71:765-767.Search in Google Scholar

17. Mygland Å, Ljøstad U, Fingerle V, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17:8-16,e1-4.Search in Google Scholar

18. Aguero-Rosenfeld ME, Wang G, Schwartz I, Wormser GP. Diagnosis of lyme borreliosis. Clin Microbiol Rev. 2005;18(3):484-509.10.1128/CMR.18.3.484-509.2005Search in Google Scholar

19. Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lyme borreliosis. Lancet Infect Dis. 2003;3(8):489-500.10.1016/S1473-3099(03)00722-9Search in Google Scholar

20. Mygland A, Ljøstad U, Fingerle V, et al. European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17(1):8-16,e1-4. doi: 10.1111/j.1468-1331.2009.02862.x.10.1111/j.1468-1331.2009.02862.xSearch in Google Scholar

21. Ljøstad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7(8):690-695. doi: 10.1016/S1474-4422(08)70119-4.10.1016/S1474-4422(08)70119-4Search in Google Scholar

22. Eikeland R, Ljøstad U, Mygland A, Herlofson K, Løhaugen GC. European neuroborreliosis: neuropsychological findings 30 months post-treatment. Eur J Neurol. 2012;19(3):480-487. doi: 10.1111/j.1468-1331.2011.03563.x.10.1111/j.1468-1331.2011.03563.x21999112Search in Google Scholar

23. Ljøstad U, Mygland A. Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors. Eur J Neurol. 2010;17(1):118-123. doi: 10.1111/j.1468-1331.2009.02756.x.10.1111/j.1468-1331.2009.02756.x19645771Search in Google Scholar